Ovintiv Inc. <OVV.N>: Wells Fargo raises target price to $79 from $78
OVV•Related News
Polyrizon completes contracts for five U.S. sites in NASARIX first-in-human seasonal allergic rhinitis trial
PLRZ•
Disc Medicine management joins fireside chats at upcoming investor conferences
IRON•
Palvella Therapeutics CEO to speak at Cantor Global Healthcare Conference 2026
PVLA•
TScan Therapeutics falls after pausing cancer trial
TCRX•
Liberty Live names Philip Boeckman chief legal officer effective Oct. 1
LLYVA•